ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $8,883,000 | -14.3% | 714,100 | -5.7% | 0.90% | -15.2% |
Q3 2016 | $10,369,000 | +16.9% | 757,400 | -36.9% | 1.06% | +14.6% |
Q2 2016 | $8,868,000 | +15.6% | 1,200,000 | 0.0% | 0.92% | +16.7% |
Q1 2016 | $7,668,000 | +2.2% | 1,200,000 | 0.0% | 0.79% | +15.1% |
Q4 2015 | $7,500,000 | +7.0% | 1,200,000 | 0.0% | 0.69% | +8.9% |
Q3 2015 | $7,008,000 | -29.4% | 1,200,000 | 0.0% | 0.63% | -22.5% |
Q2 2015 | $9,924,000 | +0.4% | 1,200,000 | 0.0% | 0.82% | +0.2% |
Q1 2015 | $9,888,000 | +19.9% | 1,200,000 | 0.0% | 0.81% | +23.5% |
Q4 2014 | $8,244,000 | +27.2% | 1,200,000 | 0.0% | 0.66% | +27.7% |
Q3 2014 | $6,480,000 | -15.2% | 1,200,000 | 0.0% | 0.52% | -16.9% |
Q2 2014 | $7,644,000 | -21.0% | 1,200,000 | 0.0% | 0.62% | -23.2% |
Q1 2014 | $9,672,000 | +18.2% | 1,200,000 | 0.0% | 0.81% | +21.8% |
Q4 2013 | $8,184,000 | +1.1% | 1,200,000 | +172.7% | 0.66% | -5.7% |
Q3 2013 | $8,096,000 | +5.2% | 440,000 | 0.0% | 0.70% | +0.6% |
Q2 2013 | $7,696,000 | – | 440,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |